Safety and Efficacy of Alteplase When Administered in Chinese Patients With Acute Ischemic Hemispheric Stroke Where Thrombolysis is Initiated Between 3 and 4.5 Hours After Stroke Onset

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

November 15, 2016

Primary Completion Date

December 11, 2017

Study Completion Date

December 11, 2017

Conditions
Stroke
Interventions
DRUG

alteplase

Trial Locations (11)

100050

Beijing Tiantan Hospital affiliated to Cap Med University, Beijing

110015

General Hospital of Shenyang Military Region, Shenyang

130031

First Hospital of Jilin University, Changchun

133000

Yanbian University Hospital, Yanji

221009

Xuzhou Central Hospital, Xuzhou

300052

Tianjin Medical University General Hospital, Tianjin

350025

No.900 Hospital of PLA Joint Logistics Support Force, Fuzhou

430060

Renmin Hospital of Wuhan University, Wuhan

510150

Third Affiliated Hospital of Guangzhou Medical University, Guangzhou

510630

The First Affiliated Hospital of Jinan University, Guangzhou

523059

Dongguan People's Hospital, Dongguan

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02930837 - Safety and Efficacy of Alteplase When Administered in Chinese Patients With Acute Ischemic Hemispheric Stroke Where Thrombolysis is Initiated Between 3 and 4.5 Hours After Stroke Onset | Biotech Hunter | Biotech Hunter